RVL PHARMACEUTICALS PLC (RVLP) Stock Analyst Ratings
USA - NASDAQ:RVLP - IE00BF2HDL56 - Common Stock
0.0282 USD
-0.01 (-32.05%)
0.0223 USD
-0.01 (-20.92%)
ChartMill assigns a Buy % Consensus number of 82% to RVLP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.21. This target is 11293.62% above the current price.
RVLP was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about RVLP.
In the previous month the buy percentage consensus was at a similar level.
RVLP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-01 | Barclays | Maintains | Overweight |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-25 | Barclays | Maintains | Overweight |
RVL PHARMACEUTICALS PLC / RVLP FAQ
What is the price target for RVLP stock?
9 analysts have analysed RVLP and the average price target is 3.21 USD. This implies a price increase of 11293.62% is expected in the next year compared to the current price of 0.0282.
What is the consensus rating for RVLP stock?
The consensus rating for RVL PHARMACEUTICALS PLC (RVLP) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.